Zobrazeno 1 - 10
of 16
pro vyhledávání: '"I González Perera"'
Autor:
JA Martin Conde, EG Fernández López, MM Viña Romero, I González Perera, J Merino Alonso, JA de Leon Gil
Publikováno v:
Section 4: Clinical Pharmacy Services.
Background and importance A hospital complex has a reference centre that is a tertiary hospital to which is attached a regional hospital located 75 km away. In 2018, in coordination with the pharmacy and haematology service, it was decided to impleme
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9c221ad651276908ae2991e2fb780de9
https://doi.org/10.1136/ejhpharm-2020-eahpconf.186
https://doi.org/10.1136/ejhpharm-2020-eahpconf.186
Autor:
MM Viña Romero, B Del Rosario Garcia, S Hernández Rojas, S García Gil, GJ Nazco Casariego, L Cantarelli, FJ Merino Alonso, J Ramos Rodríguez, I González Perera, F Gutiérrez Nicolás
Publikováno v:
Section 5: Patient Safety and Quality Assurance.
Background The HR +HER2 subtype is the most common molecular profile in women with breast cancer and the appearance of this new group of drugs has drastically changed the prognosis of this group of patients. Purpose To describe the safety profile of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::16a65a18aa48b814d83760efe8568f57
https://doi.org/10.1136/ejhpharm-2019-eahpconf.492
https://doi.org/10.1136/ejhpharm-2019-eahpconf.492
Autor:
F Gutiérrez Nicolás, GJ Nazco Casariego, S García Gil, J González García, A Madueño Alonso, I González Perera, GA González de la Fuente
Publikováno v:
Other hospital pharmacy topics.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::22867d97421954e6054d20703a01e582
https://doi.org/10.1136/ejhpharm-2017-000640.399
https://doi.org/10.1136/ejhpharm-2017-000640.399
Autor:
G Calzado Gómez, C Romero Delgado, F Gutiérrez Nicolás, T. Virgós Aller, GJ Nazco Casariego, M Bullejos Molina, I González Perera
Publikováno v:
Clinical pharmacy.
Background Immunity to malaria is complex, due to the replicative cycle of the parasite through intracellular and extracellular phases. Cellular and humoral immunity are necessary to contain the infection; it is more complicated in patients who regul
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8fae5ca3c52276cc8163d03883151d02
https://doi.org/10.1136/ejhpharm-2017-000640.166
https://doi.org/10.1136/ejhpharm-2017-000640.166
Autor:
S García Gil, GJ Nazco Casariego, MM Viña Romero, F Gutiérrez Nicolás, J Ramos Rodríguez, I González Perera, GA González de la Fuente, G Calzado Gómez
Publikováno v:
Production and preparation.
Background Oral mucositis (OM) is a frequent complication of chemotherapy which severely affects patient quality of life. Management is generally based on topical compounded formulations. Purpose To analyse the use of our compounded formulation of Li
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::54221b61ef48f125e734e00153325d4d
https://doi.org/10.1136/ejhpharm-2017-000640.500
https://doi.org/10.1136/ejhpharm-2017-000640.500
Autor:
B. Rodríguez Martín, T. Virgós Aller, Marina Rodríguez-Martín, N. Merino de Paz, A. Noda-Cabrera, I González Perera, P. Contreras Ferrer
Publikováno v:
Journal of Pediatric Infectious Diseases. :121-123
Molluscum contagiosum (MC) is a frequent viral infection in paediatric population. Destructive therapies for MC are poorly tolerated in children, so in this study, we have assessed the efficacy and tolerability of a non-painful treatment intervention
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::09920c7f3512ac15bc0cd7e555495d36
https://doi.org/10.3233/jpi-2011-0306
https://doi.org/10.3233/jpi-2011-0306
Autor:
I González Perera, J Nazco Casariego, M Suarez Gonzalez, J González García, G Calzado Gómez, M Bullejos Molina, C Romero Delgado
Publikováno v:
European Journal of Hospital Pharmacy. 23:A147.2-A148
Background Teriflunomide is an immunomodulatory agent with anti-inflammatory properties that inhibits the mitochondrial enzyme dehidroorotato-dehydrogenase (DHO-DH), which is required for the synthesis of pyrimidine, blocking the proliferation of act
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::941650325abca3830cc00144ecf2233b
https://doi.org/10.1136/ejhpharm-2016-000875.333
https://doi.org/10.1136/ejhpharm-2016-000875.333
Autor:
J Nazco Casariego, GA González de la Fuente, M Bullejos Molina, J González García, F Gutiérrez Nicolás, I González Perera
Publikováno v:
European Journal of Hospital Pharmacy. 22:A209.1-A209
Background In recent years, simplification of antiretroviral therapy is increasingly being recognised as an attractive therapeutic alternative for cost minimization. Currently, this kind of treatment is used in patients without a prior history of fai
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5d95aa903d233395e1eb83576df022ec
https://doi.org/10.1136/ejhpharm-2015-000639.512
https://doi.org/10.1136/ejhpharm-2015-000639.512
Autor:
I González Perera, GJ Nazco Casariego, C Valcarcel Nazco, F Gutiérrez Nicolás, MM Viña Romero, J González García, GA González de la Fuente
Publikováno v:
European Journal of Hospital Pharmacy. 22:A109.2-A109
Background Abiraterone is an expensive drug used in hospitals for metastatic prostate cancer and it is necessary to evaluate health outcomes from its use to establish whether it is cost-effective treatment. Purpose To analyse the effectiveness profil
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bbf728d34e54fd72b2dd57ba682d62e3
https://doi.org/10.1136/ejhpharm-2015-000639.263
https://doi.org/10.1136/ejhpharm-2015-000639.263
Autor:
S Duque Fernandez, M Bullejos Molina, F Gutiérrez Nicolás, I González Perera, GJ Nazco Casariego, M Chafer Rudilla, N Yurrebaso Eguior, J Gonzalez
Publikováno v:
European Journal of Hospital Pharmacy. 20:A10.3-A11
Background The recent marketing of new high-cost antifungal agents (echinocandins and azoles) requires the design of cost-effective treatment protocols. Purpose A new treatment guide for candidaemia and other invasive fungal infections for non-haemat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2f509200693324c16a1e84ebf9b11bbf
https://doi.org/10.1136/ejhpharm-2013-000276.028
https://doi.org/10.1136/ejhpharm-2013-000276.028